Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

124
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
124
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

107
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
107
Propagation of Uncertainty from Systematic Error01:10

Propagation of Uncertainty from Systematic Error

877
The atomic mass of an element varies due to the relative ratio of its isotopes. A sample's relative proportion of oxygen isotopes influences its average atomic mass. For instance, if we were to measure the atomic mass of oxygen from a sample, the mass would be a weighted average of the isotopic masses of oxygen in that sample. Since a single sample is not likely to perfectly reflect the true atomic mass of oxygen for all the molecules of oxygen on Earth, the mass we obtain from this...
877
Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

91
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
91
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

147
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
147
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

124
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
124

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Large language models instantiate evolutionarily robust strategies of cooperation.

PNAS nexus·2026
Same author

Using PyBioNetFit to leverage qualitative and quantitative data in biological model parameterization and uncertainty quantification.

Frontiers in immunology·2026
Same author

Structural hormesis in protein aggregation: A minimal mechanistic model.

Journal of the Royal Society, Interface·2026
Same author

Data-driven Mori-Zwanzig modeling of Lagrangian particle dynamics in turbulent flows.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Phase II Trial of Vemurafenib and Sorafenib Combination in Advanced <i>KRAS</i>-Mutated Metastatic Pancreatic Cancer.

Journal of immunotherapy and precision oncology·2026
Same author

Embryonic stem cell-derived extracellular vesicles delay cellular senescence by inhibiting oxidative stress.

The Journal of biological chemistry·2025

関連する実験動画

Updated: Sep 9, 2025

A Quantitative Fitness Analysis Workflow
11:39

A Quantitative Fitness Analysis Workflow

Published on: August 13, 2012

14.6K

PyBioNetFitを使用して,生物モデルのパラメータ化および不確実性の定量化における定性および定量データを活用する.

Ely F Miller, Abhishek Mallela, Jacob Neumann

    ArXiv
    |September 5, 2025
    PubMed
    まとめ

    この研究では,定性データを用いて細胞システムの数学モデルをパラメータ化するための新しい方法が紹介されています. PyBioNetFitソフトウェアは,システム生物学モデルの再現可能な分析と不確実性の定量化を可能にします.

    科学分野:

    • システム生物学
    • コンピュータ生物学
    • セルラー・シグナル

    背景:

    • 細胞の調節系の研究は,数学的モデルに統合するのが難しいランクオーダーレスポンスのような定性的なデータをしばしば得ます.
    • 定性データを通常の微分方程式 (ODE) モデルに組み込む以前の方法は,しばしばアドホックであり,再現できず,不確実性の定量化が欠けていました.

    研究 の 目的:

    • 定性データと定量データの両方を用いて,セルラー規制システムのODEモデルをパラメータ化するための体系的かつ自動化されたアプローチを開発する.
    • 数学的モデリングにおける質的生物学的観測の再利用性を向上させる.
    • システム生物学モデルのパラメータ化において不確実性定量化 (UQ) を実施する.

    主な方法:

    • 生物学的なデータから定性的な観察を公式にします.
    • PyBioNetFitソフトウェアパッケージを自動モデルのパラメータ化に使用した.
    • ODEモデルフレームワーク内の統合された質的および定量的データ.
    • 不確実性の定量化 (UQ) を行いました.

    主要な成果:

    • PyBioNetFitはモデルのパラメータ化のために定性データと定量データをうまく活用しました.

    さらに関連する動画

    High-Throughput Metabolic Profiling for Model Refinements of Microalgae
    11:07

    High-Throughput Metabolic Profiling for Model Refinements of Microalgae

    Published on: December 4, 2021

    3.9K
    High-Resolution Neutron Spectroscopy to Study Picosecond-Nanosecond Dynamics of Proteins and Hydration Water
    08:48

    High-Resolution Neutron Spectroscopy to Study Picosecond-Nanosecond Dynamics of Proteins and Hydration Water

    Published on: April 28, 2022

    1.8K

    関連する実験動画

    Last Updated: Sep 9, 2025

    A Quantitative Fitness Analysis Workflow
    11:39

    A Quantitative Fitness Analysis Workflow

    Published on: August 13, 2012

    14.6K
    High-Throughput Metabolic Profiling for Model Refinements of Microalgae
    11:07

    High-Throughput Metabolic Profiling for Model Refinements of Microalgae

    Published on: December 4, 2021

    3.9K
    High-Resolution Neutron Spectroscopy to Study Picosecond-Nanosecond Dynamics of Proteins and Hydration Water
    08:48

    High-Resolution Neutron Spectroscopy to Study Picosecond-Nanosecond Dynamics of Proteins and Hydration Water

    Published on: April 28, 2022

    1.8K
  • 自動化されたアプローチは再現性を改善し,以前の方法では存在しない不確実性の定量化が可能になりました.
  • システム生物学におけるモデルパラメータのより信頼性の高い推定を示した.
  • 結論:

    • PyBioNetFitは,システム生物学モデリングに定性データと定量データを統合するための堅固な枠組みを提供します.
    • 開発された方法は,パラメータ推定の信頼性を高め,重要な不確実性の定量化を促進します.
    • このアプローチは,再現可能で洞察力のある細胞制御システムの分析に不可欠です.